Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sio Capital Management | 2.1M | $1.4M | 100% | Dec 2025 |
|
| Vanguard Group | 1.3M | $804k | 0% | Dec 2025 |
|
| Gilead Sciences | 650k | $5.5M | -93% | Mar 2026 |
|
| FMR | 512k | $328k | 0% | Dec 2025 |
|
| Renaissance Technologies | 344k | $221k | 68% | Dec 2025 |
|
| State Street Corporation | 186k | $119k | 14% | Dec 2025 |
|
| Velan Capital Investment Management | 170k | $109k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 126k | $81k | 100% | Dec 2025 |
|
| Northern Trust | 67k | $43k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 56k | $36k | 0% | Dec 2025 |
|
| Raymond James Financial | 19k | $12k | 0% | Dec 2025 |
|
| XTX Topco | 17k | $11k | -77% | Dec 2025 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bain Capital Life Sciences Investors | Dec 2025 | 7.4M | $4.7M |
| Frazier Life Sciences Management | Dec 2025 | 5.9M | $3.8M |
| Point72 Asset Management | Dec 2025 | 4.0M | $2.6M |
| Stempoint Capital | Dec 2025 | 2.0M | $1.3M |
| Merck & Co | Dec 2025 | 1.5M | $950k |
| Empery Asset Management | Dec 2025 | 1.2M | $757k |
| Ghisallo Capital Management | Dec 2025 | 1.1M | $713k |
| AJU IB Investment | Dec 2025 | 668k | $428k |
| Citadel Advisors | Dec 2025 | 436k | $279k |
| Geode Capital Management | Dec 2025 | 329k | $211k |
| GSA Capital Partners | Dec 2025 | 148k | $95k |
| Two Sigma Investments | Dec 2025 | 62k | $40k |
| Jane Street | Dec 2025 | 42k | $27k |
| Hrt Financial | Dec 2025 | 32k | $20k |
| Mariner Wealth Advisors | Dec 2025 | 25k | $16k |
| LPL Financial | Dec 2025 | 21k | $13k |